000 01412 a2200421 4500
005 20250515034202.0
264 0 _c20061207
008 200612s 0 0 spa d
022 _a0014-2565
024 7 _a10.1157/13090517
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aFormiga, F
245 0 0 _a[Risperidone and cerebrovascular adverse effects in elderly patients with dementia].
_h[electronic resource]
260 _bRevista clinica espanola
_cSep 2006
300 _a411-2; author reply 412-3 p.
_bdigital
500 _aPublication Type: Letter; Comment
650 0 4 _aAged
650 0 4 _aAged, 80 and over
650 0 4 _aAntipsychotic Agents
_xadverse effects
650 0 4 _aCerebrovascular Disorders
_xetiology
650 0 4 _aCholinesterase Inhibitors
_xtherapeutic use
650 0 4 _aDementia, Vascular
_xdrug therapy
650 0 4 _aDonepezil
650 0 4 _aFemale
650 0 4 _aGalantamine
_xtherapeutic use
650 0 4 _aHumans
650 0 4 _aIndans
_xtherapeutic use
650 0 4 _aMale
650 0 4 _aPiperidines
_xtherapeutic use
650 0 4 _aRisperidone
_xadverse effects
700 1 _aFort, I
700 1 _aPérez-Castejón, J M
700 1 _aRuiz, D
700 1 _aDuaso, E
700 1 _aRiu, S
773 0 _tRevista clinica espanola
_gvol. 206
_gno. 8
_gp. 411-2; author reply 412-3
856 4 0 _uhttps://doi.org/10.1157/13090517
_zAvailable from publisher's website
999 _c16453388
_d16453388